Nguyen, Quan Dong
11 papers on CoChatORCID 0000-0002-6024-8441
Most cited papers
- Verified
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 2,485
- Verified
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 982
- Verified
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine
Psoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and Therapies
Cited by 860
- Verified · note
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
Schmidt-Erfurth, U., Kaiser, P. K., Korobelnik, J.-F., Brown, D. M., Chong, V., Nguyen, Q. D., Ho, A. C., Ogura, Y., Simader, C., Jaffe, G. J., et al. (2014) · Ophthalmology
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 822
- Verified
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Heier, J. S., Lad, E. M., Holz, F. G., Rosenfeld, P. J., Guymer, R. H., Boyer, D., Grossi, F., Baumal, C. R., Korobelnik, J.-F., Slakter, J. S., et al. (2023) · The Lancet
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 520
- Verified
Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial
Campochiaro, P. A., Nguyen, Q. D., Shah, S. M., Klein, M. L., Holz, E., Frank, R. N., Saperstein, D. A., Gupta, A., Stout, J. T., Macko, J., et al. (2006) · Human Gene Therapy
Retinal Diseases and TreatmentsVirus-based gene therapy research
Cited by 343
- Verified · note
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis
Dick, A. D., Rosenbaum, J. T., Al-Dhibi, H. A., Belfort, R., Brézin, A. P., Chee, S. P., Davis, J. L., Ramanan, A. V., Sonoda, K.-H., Carreño, E., et al. (2018) · Ophthalmology
Ocular Diseases and Behçet’s SyndromeSpondyloarthritis Studies and Treatments
Cited by 285
- Verified
Mycophenolate Mofetil Therapy for Inflammatory Eye Disease
Thorne, J. E., Jabs, D. A., Qazi, F. A., Nguyen, Q. D., Kempen, J. H., & Dunn, J. P. (2005) · Ophthalmology
Ocular Diseases and Behçet’s SyndromeDrug-Induced Ocular Toxicity
Cited by 219
- Verified
Aflibercept for neovascular age-related macular degeneration
Sarwar, S., Clearfield, E., Soliman, M. K., Sadiq, M. A., Baldwin, A. J., Hanout, M., Agarwal, A., Sepah, Y. J., Do, D. V., & Nguyen, Q. D. (2016) · Cochrane Database of Systematic Reviews
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 142
- Verified
Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations
Jain, A., Chea, S., Matsumiya, W., Halim, M. S., Yaşar, Ç., Kuang, G., Sepah, Y. J., Khanani, A. M., Do, D. V., & Nguyen, Q. D. (2020) · American Journal of Ophthalmology Case Reports
Retinal Diseases and TreatmentsRetinal and Optic Conditions
Cited by 109
- Verified
Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 76
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free